The latest genitourinary oncology news
Hormones contribute to sex disparities in bladder cancer, study shows
Male sex hormones interfere with the body’s ability to fight bladder cancer, likely explaining why…
Browsing: GU Cancers
ASCO 2022: Cell-free DNA methylation used to predict chemo benefit in bladder cancer
A team of researchers from SWOG Cancer Research Network, a cancer clinical trials group funded…
First mutation-targeted bladder cancer drug may be under-used
The first bladder cancer drug targeting a cancer-driving gene mutation has been used relatively little…
Lung cancer drug could improve survival rates for bladder cancer patients undergoing chemotherapy
Scientists from the University of Sheffield, UK, have discovered a drug already used to treat…
Therapeutically effective drugs identified for bladder cancer
Hundreds of chemical compounds were screened on cell cultures representing different stages and subtypes of…
ASCO GU 2022: Enfortumab vedotin is effective in patients with aggressive bladder cancer
Findings from a new study led by Yale Cancer Center researchers show enfortumab vedotin is effective in…
ASCO GU 2022: Biomarker may help predict survival in patients with bladder cancer
Long-term survival data from the first prospective, randomized biomarker validation trial in patients with muscle-invasive…
Belzutifan induced strong responses in patients with von Hippel-Lindau disease-associated kidney cancer
Results from a Phase II trial led by researchers at The University of Texas MD…
Israel’s quality indicators show increase in breast and colorectal cancer screening, lag in cervical screenings
Researchers from Hebrew University-Hadassah in Jerusalem, Israel, and Cardioinfantil Foundation, Cardiology Institute in Bogota, Colombia,…
ESMO 2021: NORSE Study
Highlights on erdafitinib in advanced urothelial cancer with FGFRa alterations: The NORSE study